Glenmede Trust’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,588
| Closed | -$408K | – | 1308 |
|
|
2021
Q1 | $408K | Buy |
3,588
+43
| +1% | +$4.89K | ﹤0.01% | 901 |
|
|
2020
Q4 | $490K | Buy |
3,545
+371
| +12% | +$51.3K | ﹤0.01% | 848 |
|
|
2020
Q3 | $260K | Buy |
3,174
+3,160
| +22,571% | +$259K | ﹤0.01% | 960 |
|
|
2020
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 2359 |
|
|
2020
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 3050 |
|
|
2019
Q4 | $0 | Hold |
14
| – | – | ﹤0.01% | 3105 |
|
|
2019
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 3095 |
|
|
2019
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 3149 |
|
|
2019
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 3157 |
|
|
2018
Q4 | $0 | Buy |
+14
| New | – | ﹤0.01% | 3073 |
|
|
2016
Q4 | – | Sell |
-14
| Closed | – | – | 2592 |
|
|
2016
Q3 | $0 | Buy |
+14
| New | – | ﹤0.01% | 2661 |
|
|
2016
Q1 | – | Sell |
-24
| Closed | -$2K | – | 2704 |
|
|
2015
Q4 | $2K | Hold |
24
| – | – | ﹤0.01% | 2466 |
|
|
2015
Q3 | $2K | Hold |
24
| – | – | ﹤0.01% | 2519 |
|
|
2015
Q2 | $2K | Sell |
24
-33
| -58% | -$2.75K | ﹤0.01% | 2456 |
|
|
2015
Q1 | $3K | Buy |
+57
| New | +$3K | ﹤0.01% | 2328 |
|